MusclePharm Closes $500,000 in Initial Orders for MP Performance Energy Line Through Collective Distributors
MusclePharm Corporation (OTCMKTS: MSLP) has secured $500,000 in initial orders for its new energy drink line, MP Performance Energy, set to ship in summer 2021. CEO Ryan Drexler expressed enthusiasm over the strong pre-order response and mentioned plans to donate 2,500 cases of the product to first responders. Additionally, a charitable fund will be established once sales reach $1 million. The announcement reflects the company's growth potential in the sports nutrition sector amidst a competitive market.
- Secured $500,000 in pre-orders for MP Performance Energy.
- Plans to donate 2,500 cases of MP Performance Energy to first responders.
- Potential risks include declines in consumer spending and competition from other nutrition providers.
- Forward-looking statements may not guarantee future sales and could be impacted by market conditions.
CALABASAS, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported that they have closed
Mr. Ryan Drexler, MusclePharm’s CEO and Chairman of the Board, stated, “I’m very excited to announce that MusclePharm has sold
Mr. Drexler continued, “I’d also like to announce that in honor of reaching this milestone, MusclePharm will donate 2,500 cases of MP Performance Energy to first responders across the United States. These cases will be distributed once the pre-orders ship. I’m also excited to share that once we reach our next goal of
MP Performance Energy is slated to begin distribution in summer, 2021.
Forward-Looking Statement
This communication contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, relating to our business and financial outlook, which are based on our current beliefs, assumptions, expectations, estimates, forecasts and projections. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “intends,” “predicts,” “potential,” or “continue” or other comparable terminology. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, risks relating to consumer spending may decline or that U.S. and global macroeconomic conditions may worsen resulting in reduced demand for the Company’s products, risks relating to changes in consumer preferences away from the Company’s offerings, risks relating to the effectiveness and efficiency of the Company’s advertising campaigns and marketing expenditures, including existing brands and the launch of new brands, which may not result in increased revenue or generate sufficient levels of brand name and program awareness, risks if the Company becomes subject to health or advertising related claims from its customers, competitors or governmental and regulatory bodies, and risks relating to increased competition from other nutrition providers. As a result of these various risks, our actual outcomes and results may differ materially from those expressed in these forward-looking statements.
This list of risks, uncertainties and other factors is not complete. We discuss some of these matters more fully, as well as certain risk factors that could affect our business, financial condition, results of operations, and prospects, in reports we file from time-to-time with the SEC, which are available to read at www.sec.gov. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the results of any revisions to the forward-looking statements made in this press release.
About MusclePharm Corporation
MusclePharm® is an award-winning, worldwide leading sports nutrition & lifestyle company offering branded nutritional supplements. Its portfolio of recognized properties include the MusclePharm® Sport Series, Essentials Series, and recently-launched Natural Series, as well as FitMiss™ – a product line designed specifically for female athletes. MusclePharm® products are available in more than 100 countries globally, with its Combat Protein product lineup being the company’s most popular.
Contact:
John Mills, Managing Partner
ICR, Inc.
646-277-1254
John.Mills@Icrinc.com
FAQ
What are the initial orders reported by MusclePharm for MSLP?
When will MusclePharm's MP Performance Energy start shipping?
What is MusclePharm's plan for charitable donations?
What challenges does MusclePharm face in the market?
What milestone will trigger the establishment of a charitable fund for MusclePharm?
